Endoscopic treatment of primary grade V vesicoureteral reflux using hyaluronic acid copolymer (DX/HA)

被引:8
作者
Hunziker, Manuela [2 ]
Mohanan, Nochiparambil [1 ]
D'Asta, Federica [2 ]
Puri, Prem [1 ,2 ]
机构
[1] Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland
[2] Natl Childrens Hosp, Dublin, Ireland
关键词
Vesicoureteral reflux; Endoscopic treatment; Renal scarring; MANAGEMENT;
D O I
10.1007/s00383-010-2650-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Since DX/HA was approved by the Food and Drug Administration in 2001 as an acceptable tissue-augmenting substance for subureteral injection, endoscopic treatment has become increasingly popular for treating vesicoureteral reflux (VUR). However, most paediatric urologists still continue to recommend ureteral reimplantation as the treatment of choice in the management of grade V VUR. The purpose of this study was to prospectively evaluate the effectiveness of endoscopic subureteral injection of DX/HA in the treatment of grade V reflux. During 2001-2009, 56 children (35 males, 21 females) with primary grade V VUR underwent endoscopic treatment using DX/HA. Their ages ranged from 4 months to 11 years. Forty-nine patients had unilateral grade V VUR, and seven had bilateral grade V (63 refluxing ureters including 17 duplex systems). Renal scarring on dimercaptosuccinic acid was observed in 39 kidneys (mild scarring 13, moderate scarring 14 and severe scarring 12). In all patients, endoscopic injection was made after inserting the needle within the wide ureteral orifice. Renal ultrasound and voiding cystourethrogram was performed 3 months after the endoscopic treatment. If VUR had not resolved, the patient was considered for further endoscopic treatment. After the VUR was resolved, children were followed with renal ultrasound at 1 year and every 2 years thereafter. The VUR completely resolved after first injection of DX/HA in 33 (52.4%) ureters and downgraded to grade I VUR in 7 (11.1%) ureters. 19 (30.2%) ureters required a second injection, and 4 (6.3%) ureters required a third injection to resolve VUR. No children in this series needed reimplantation of ureters or presented with ureteral obstruction during follow-up. Endoscopic treatment with DX/HA is effective in eradicating grade V primary reflux. This simple and minimally invasive treatment should be offered to all parents of children with grade V VUR as an alternative to ureteral reimplantation.
引用
收藏
页码:977 / 979
页数:3
相关论文
共 50 条
[41]   Routine delayed voiding cystourethography after initial successful endoscopic treatment with Dextranomer/Hialuronic Acid Copolimer (Dx/HA) of vesicoureteral reflux (VUR). Is it necessary? [J].
Garcia-Aparicio, L. ;
Blazquez-Gomez, E. ;
Santandreu, A. Vila ;
Diaz, J. A. Camacho ;
Vila-Cots, J. ;
Cebrian, M. Ramos ;
de Haro, I. ;
Martin, O. ;
Tarrado, X. .
Actas Urologicas Espanolas, 2016, 40 (10) :635-639
[42]   Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results [J].
Friedmacher, Florian ;
Colhoun, Eric ;
Puri, Prem .
JOURNAL OF UROLOGY, 2018, 200 (03) :650-655
[43]   Long-term preservation of dextranolrner/hyaluronic acid copolymer implants after endoscopic treatment of vesicoureteral reflux in children: A sonographic volumetric analysis [J].
McMann, Leah P. ;
Scherz, Hal C. ;
Kirsch, Andrew J. .
JOURNAL OF UROLOGY, 2007, 177 (01) :316-320
[44]   Injection volumes of dextranomer/hyaluronic acid are increasing in the endoscopic management of vesicoureteral reflux [J].
Mathew D. Sorensen ;
Martin A. Koyle ;
Charles A. Cowan ;
Ismael Zamilpa ;
Margarett Shnorhavorian ;
Thomas S. Lendvay .
Pediatric Surgery International, 2010, 26 :509-513
[45]   Injection volumes of dextranomer/hyaluronic acid are increasing in the endoscopic management of vesicoureteral reflux [J].
Sorensen, Mathew D. ;
Koyle, Martin A. ;
Cowan, Charles A. ;
Zamilpa, Ismael ;
Shnorhavorian, Margarett ;
Lendvay, Thomas S. .
PEDIATRIC SURGERY INTERNATIONAL, 2010, 26 (05) :509-513
[46]   Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux [J].
Puri, Prem ;
Pirker, Martina ;
Mohanan, Nochiparambil ;
Dawrant, Michal ;
Dass, Laxman ;
Colhoun, Eric .
JOURNAL OF UROLOGY, 2006, 176 (04) :1856-1859
[47]   Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene [J].
Chertin, B ;
De Caluwé, D ;
Puri, P .
JOURNAL OF UROLOGY, 2003, 169 (05) :1847-1849
[48]   Single Center Experience with Endoscopic Subureteral Dextranomer/Hyaluronic Acid Injection as First Line Treatment in 1,551 Children with Intermediate and High Grade Vesicoureteral Reflux [J].
Puri, Prem ;
Kutasy, Balazs ;
Colhoun, Eric ;
Hunziker, Manuela .
JOURNAL OF UROLOGY, 2012, 188 (04) :1485-1489
[49]   Prospective Study of Polydimethylsiloxane vs Dextranomer/Hyaluronic Acid Injection for Treatment of Vesicoureteral Reflux [J].
Moore, Katherine ;
Bolduc, Stephane .
JOURNAL OF UROLOGY, 2014, 192 (06) :1794-1799
[50]   Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction [J].
Lackgren, Goran ;
Skoldenberg, Erik ;
Stenberg, Arne .
JOURNAL OF UROLOGY, 2007, 177 (03) :1124-1128